Regulation (EU) 2020/1043 of the European Parliament and of the Council of 15 July 2020 on the conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or prevent coronavirus disease (COVID-19) (Text with EEA relevance)
Basic information
Dates Date of document:
  • July 15, 2020
Date of publication:
  • July 17, 2020
Date of effect:
  • July 18, 2020
    • Entry into force - Date pub. +1 See Art 5
Modified by
Modifies
Derogation:
Affected by case
Legal basis
  • Consolidated version of the Treaty on the Functioning of the European Union PART THREE - UNION POLICIES AND INTERNAL ACTIONS TITLE XIV - PUBLIC HEALTH Article 168 (ex Article 152 TEC)
  • Consolidated version of the Treaty on the Functioning of the European Union PART THREE - UNION POLICIES AND INTERNAL ACTIONS TITLE VII - COMMON RULES ON COMPETITION, TAXATION AND APPROXIMATION OF LAWS CHAPTER 3 - APPROXIMATION OF LAWS Article 114 (ex Article 95 TEC)
EuroVoc Vocabulary
  • Medical research
  • Marketing standard
  • Public health
  • Infectious disease
  • Research and technological development
  • Health protection
  • Proprietary medicinal products
  • Testing
  • Disease prevention
  • Pharmaceutical legislation
  • Public health
  • Medicinal product
  • Epidemic
  • Genetically modified organism